Philip Hampton

UK pharmaceutical company GlaxoSmithKline is poised to name Jonathan Symonds, a former executive at rivals AstraZeneca and Novartis, as its next chair(...)

European shares slipped on Monday from six-week highs after China’s fourth-quarter growth figures confirmed a slowdown in the world’s second biggest e(...)

GlaxoSmithKline chairman Philip Hampton is to step down from the drugmaker, just a month after the company fired the starting gun on its break-up. Th(...)

Women aren’t able to understand the “extremely complex” issues Ftse boards deal with, they don’t want the “hassle or pressure” of sitting on a top boa(...)

Britain is planning to sell half its stake in Royal Bank of Scotland, worth £16 billion, within two years, according to sources have said. Chancellor (...)

GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers.G(...)

Sir Philip Hampton is in line to become GlaxoSmithKline’s next chairman after more than five years overseeing the restructuring of Royal Bank of Scotl(...)

The spectre of Britain’s most reviled company boss, the former RBS chief executive Fred Goodwin, was invoked yesterday by a government minister as he (...)

British business minister Vince Cable has indicated that Ulster Bank parent RBS will be in public hands for another five years, according to the Sunda(...)

Britain is ready to start selling its shares in Lloyds Banking Group and will examine whether to break up Royal Bank of Scotland, finance minister Geo(...)